OnKure (OKUR) CEO Nicholas A. Saccomano Sells 87 Shares

What Happened

• Nicholas A. Saccomano, President, CEO and Director of OnKure Therapeutics (OKUR), disposed of 87 shares on 2026-09-21 in an open-market/private sale. The weighted-average price was $2.97 per share for total proceeds of approximately $259. The sale was executed to cover tax-withholding obligations tied to the vesting of restricted stock units (RSUs).

Key Details

• Transaction date: 2026-09-21; Form 4 filed 2026-09-23 (generally within the two-business-day reporting window).
• Shares sold: 87; weighted-average sale price: $2.97; total value ≈ $259.
• Price range: individual trades ranged from $2.95 to $3.06 (weighted average reported; the filer can provide per-trade details on request).
• Reason/footnote: automatic sale to satisfy tax withholding on RSU vesting under the Issuer’s 2023 RSU Equity Incentive Plan (footnotes F1–F3).
• Shares owned after the transaction: not specified in the provided filing.

Context

• These were RSU-related sales to satisfy tax obligations (a routine, non-discretionary transaction), not a discretionary open-market sale for investment purposes. Such tax-withholding disposals are common when equity awards vest and generally don’t signal management’s market view.